MIRA-55 shows pain relief comparable to Celebrex
MIRA Pharmaceuticals posted positive preclinical results for its pain drug candidate MIRA-55, demonstrating the potential to rival popular drugs like Celebrex for chronic inflammatory pain without observed tolerance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed